Yes the company is going to be, or may already be, investigated by the fda for marketing practice issues that do not reflect what actually their agent is doing. Does this surprise anyone? They took reps direct, messed with their commission schedules instantly and now you have people walking to the exits already. They are not even that good, just expensive.
Untill Medicare changes their reimbursement issues, this product is dead in the water along with the stock.